The plan includes funding for a pilot program aimed at controlling tick populations and finding better Lyme disease and alpha-gal syndrome treatments.
The Vaccines and Related Biological Products Advisory Committee will decide tomorrow on the composition of next fall’s COVID vaccine.
Although the new vaccine fell short of its primary goal, it showed ‘clinically meaningful’ results in a secondary analysis.
Patients with Lyme disease incurred nearly $4,100 more in health care costs over 6 months.
The test had 91% sensitivity in detecting Borrelia burgdorferi.
Nineteen-month antibody geometric mean titers were higher among children than in adults, similar to after the primary series.
A high percentage of respondents said they were aware of the tick-borne disease and spent time outdoors, but less than half said they took measures to prevent infection.
The highest rates of disseminated disease were in older Black Medicare beneficiaries and pediatric Black Medicaid beneficiaries.
The authors say future research must use biobanks for data collection.
Herbs and supplements are the most common treatment offered by the clinics.
